BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB.

View / Open Files

Published version (PDF, 3Mb)

Authors

Li, Chuwen

Chen, Tongkai

Zhou, Hefeng

Feng, Yu

Hoi, Maggie PM

Ma, Dan

  Zhao, Chao

  Zheng, Ying

Lee, Simon MY

Show moreShow less

Publication Date

2018-01

Journal Title

Frontiers in pharmacology

ISSN

1663-9812

Volume

9

Pages

614

Language

eng

Type

Article

Physical Medium

Electronic-eCollection

Metadata

Show full item record

Citation

Li, C., Chen, T., Zhou, H., Feng, Y., Hoi, M. P., Ma, D., Zhao, C., et al. (2018). BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB.. Frontiers in pharmacology, 9 614. https://doi.org/10.3389/fphar.2018.00614

Identifiers

External DOI: https://doi.org/10.3389/fphar.2018.00614

This record's URL: https://www.repository.cam.ac.uk/handle/1810/283050



Rights

Attribution 4.0 International

Licence URL: https://creativecommons.org/licenses/by/4.0/